Disc Medicine Stock
Disc Medicine is a clinical-stage biopharmaceutical company developing innovative therapies for hematologic disorders. Focused on red blood cell biology, including heme biosynthesis and iron homeostasis, the company aims to deliver transformative treatments that improve patient lives.
Founded: 2017
For more Disc Medicine stock information, or to buy or sell private shares, sign up for a MicroVentures account.
Management Team
| John Quisel, JD, PhD Chief Executive Officer |
| Jean Franchi Chief Financial Officer |
| Jonathon Yu Chief Operating Officer |
| Will Savage, MD, PhD Chief Medical Officer |
